Abstract

29
Interactions between the gut microbiota and the host are important for health, where dysbiosis has 30 emerged as a likely component of mucosal disease. The specific constituents of the microbiota that 31 contribute to mucosal disease are not well defined. We sought to define microbial components that 32 regulate homeostasis within the intestinal mucosa. Using an unbiased, metabolomic profiling approach, 33 we identified a selective depletion of indole and indole-derived metabolites in murine and human colitis.
34
We demonstrated that indole-3-propionic acid (IPA) was selectively diminished in circulating serum from 35 human subjects with active colitis and that IPA served as a biomarker of disease remission. The mammalian gastrointestinal (GI) tract plays host to trillions of microbes, collectively termed 49 the microbiota, where a critical mutualism exists within the intestinal mucosa. The microbiota contributes 50 significantly to gut homeostasis but can also contribute to establishing and maintaining mucosal disease 1 .
51
Intestinal mucosal surfaces act as primary barriers to microbial invasion, where commensal bacteria work 52 in a dynamic and intimate interaction with the gut epithelium and influence host cellular and immune 53 responses 2 . Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the GI tract that is 54 comprised of Crohn's disease (CD) and ulcerative colitis (UC). It is known that IBD is caused by 55 interactions between genetic and environmental factors, and results in perturbations of the microbiota, 56 though precisely how microbial factors affect gut homeostasis and immune response have not been 57 extensively explored 3-5 .
58
The significance of IL-10 signaling is well established in IBD. This anti-inflammatory cytokine, 59 which signals through the IL-10 receptor ligand-binding subunit (IL-10R1), is induced during 60 inflammation and attenuates excessive production of pro-inflammatory mediators in various cell types, 61 including intestinal epithelial cells (IEC) 6, 7 . Functional IL-10 signaling is associated with enhanced 62 mucosal barrier function and results in maintenance and homeostasis of the epithelia 7 . Previous work, 63 including our own, has shown that the epithelial IL-10R1 contributes fundamentally to resistance to 64 intestinal inflammation and represents a component of epithelial innate immunity originally described to 65 be induced by cytokines such as IFN-γ 8 . For instance, mice deficient in IL-10 or IL-10 receptor develop 66 spontaneous severe colitis and mice conditionally lacking intestinal epithelial IL-10R1 show increased 67 susceptibility to colitis 7, 9, 10 .
68
Metabolomic analysis has revealed that gut bacteria impact host immunity through a variety of 69 metabolites, including indole metabolites 11 , which originate from the microbial metabolism of 70 tryptophan. Indole-3-propionic acid (IPA) and indole-3-aldehyde (IAld), which are tryptophan 71 metabolites produced by intestinal bacteria, are known for their intercellular signaling activity. Further, 4 IAld has recently been identified as an aryl hydrocarbon receptor (AHR) ligand 12 . AHR is a ligand-73 dependent transcription factor activated by a variety of synthetic and biological molecules that plays an 74 important role in immunological response and inhibition of inflammation 13 . AHR contributes to immune 75 homeostasis through various methods, including T cell differentiation and Th17 development 14, 15 , as well 76 as the upregulation of IL-22 production 16 Figure 1A ). Tryptophan is metabolized through various pathways, including the indole 232 pathway, resulting in derivatives that are produced from metabolism by gut microbiota ( Figure 1B ).
233
Colitis profoundly altered tryptophan metabolism, specifically revealing a selective decrease in indole 234 metabolites. To validate this mass spectrometry-based metabolite screen, we developed an HPLC-based 235 protocol using electrochemical (EC) detection methods ( Figure 1C ). Eight-to ten-week-old C57BL/6 236 mice were administered water or 2.5% DSS ad libitum for 9 d. DSS was then removed and mice were 237 allowed to recover for 2 d prior to euthanasia. Serum indole metabolites were profiled by EC-HPLC 238 ( Figure 1D ). Serum indole and IPA levels were significantly decreased in actively colitic animals (P < 239 0.05). A marked decrease in serum IAld was also observed (P = 0.09). It is notable that overall tryptophan 240 levels in DSS colitis actually increase ( Figure 1A ), suggesting that our findings of indole depletion are not 241 a result of diminished tryptophan absorption.
242
Guided by results of indole depletion in active murine colitis, we attempted to translate our results 243 to human patients. Here, we used our developed EC-HPLC method to quantify various indole metabolites 244 in serum samples from patients with UC. For these purposes, serum samples from healthy controls (n = 245 20), subjects with active UC (n = 15), and subjects with UC in remission (n = 20) were profiled (see 246 Table 2 for demographics). This analysis revealed that serum IPA was deceased by nearly 60% in 247 subjects with active UC compared to healthy controls (P < 0.05, Figure 1E ). Notably, this IPA deficiency 
268
We next examined the influence of the metabolite IAld on barrier formation in T84 cell 269 monolayers, as our previous work has demonstrated that IL-10 signaling is important in IEC barrier 270 development and maintenance 7, 23 . Cells exposed to both IAld and IL-10 exhibited significantly increased 271 barrier formation at 72 h compared with untreated cells as measured by TEER (P < 0.01; Figure 2D ). modulates IL-10R1 expression via an AHR-mediated mechanism (P < 0.05, Figure 3F ). These results 296 suggest that the AHR pathway is involved in the indole metabolite-dependent expression of IL-10R1 in 297 IEC.
299
Bacterial indole production induces IL-10R1
We next sought to determine whether microbe-derived sources of indole could similarly regulate 301 epithelial target genes. For these purposes, we targeted indole production in Escherichia coli (E. coli).
302
Indole is synthesized from tryptophan by microbial tryptophanase 29 . Using Kovac's reagent to test for the 303 presence of indole, we show that an E. coli K12 strain (E. coli BW25113; WT) clearly produced indole 304 ( Figure 4A ), whereas deletion of the tryptophanase gene (∆tnaA) revealed a lack of detectable indole.
305
Conversely, deletion of one of the tryptophan transporters (∆tnaB) does not compromise indole 306 production ( Figure 4A ). To validate these observations, the presence of indole in cell-free supernatants of 307 bacteria was examined by EC-HPLC. While E. coli WT bacteria exhibited readily detectable levels of 308 indole, metabolism of tryptophan to indole was completely abolished in E. coli ∆tnaA ( Figure 4B ). To test 309 the activity of this microbial-derived indole, cell-free supernatants from E. coli WT and ∆tnaA mutant 310 were serially diluted and exposed to T84 IEC for 24 h. Supernatants from E. coli WT readily induced IL-311 10R1 protein expression, while minimal IL-10R1 induction was observed in cells exposed to E. coli 312 ∆tnaA supernatant ( Figure 4C ).
313
We extended these findings to an in vivo model. Herein, we examined the function of indole-314 producing bacteria on epithelial IL-10R1 in germ-free mice. Germ-free mice were colonized with E. coli 315 WT or E. coli ∆tnaA for 2 wk followed by euthanasia. Fresh fecal pellets were collected periodically for 316 plating to ensure equal colonization, quantified as bacterial CFU per g of feces (data not shown). Indole 317 concentrations in cecal contents were validated by HPLC in vehicle and colonized animals. Mice 318 monocolonized with E. coli WT displayed significantly increased cecal indole, while negligible levels 319 were measured in PBS-and E. coli ∆tnaA-gavaged animals (P < 0.01; Figure 4D ). Further, colons were 320 harvested and RNA extracted for qPCR analysis. This strategy revealed that mice monocolonized with E. 321 coli WT displayed significantly increased colonic il10r1 expression, while no significant il10r1 induction 322 was observed in colon tissue of mice colonized with E. coli ∆tnaA mutant (P < 0.05; Figure 4E ). Taken 323 together, these in vitro and in vivo results strongly support our hypothesis that microbe-derived indoles 324 promote epithelial homeostasis.
IPA improves DSS colitis outcomes
327
Given the observation that indole metabolites are significantly decreased in active colitis, we 328 tested the therapeutic potential of IPA in murine colitis outcomes. For these purposes, mice were 329 administered either normal drinking water, DSS (2.5% wt/vol) or a combination of DSS and IPA (0.1 330 mg/ml) in drinking water for 9 d, followed by DSS removal and a 2-d recovery. To verify that oral 331 administration normalized IPA levels, colonic IPA was quantified by EC-HPLC. This analysis revealed 332 that while DSS colitic mice displayed significantly lower levels of IPA, oral administration of IPA 333 normalized colonic levels of this metabolite (P < 0.01; Figure 5A ). Under these treatment conditions, 334 DSS/IPA-treated animals displayed significantly less reduction in colon length, a marker of intestinal 335 inflammation, compared to DSS-treated animals (P < 0.05; Figure 5B ). Histological analysis revealed that 336 DSS/IPA-treated mice displayed attenuated inflammatory infiltration and decreased loss of architecture in 337 comparison to mice treated with DSS alone, which displayed pronounced loss of epithelium and tissue 338 architecture ( Figure 5C ). These differences resulted in greater histopathological severity scores (P < 339 0.001; Figure 5D ). We additionally examined tissue cytokine levels in these mice. Pro-inflammatory 340 cytokine levels were dramatically increased in DSS-treated mice, specifically IFN-γ (P < 0.05; Figure   341 5E), TNF-α (P < 0.01; Figure 5F ), and IL-1β (P < 0.05; Figure 5G ), while cytokine levels in DSS/IPA-342 treated mice were similar to mice administered water alone. Similarly, IL-10 levels were significantly 343 increased in DSS-treated mice, though IPA administration did not alter levels of this cytokine 344 (Supplemental Figure S1 ). Further, IPA administration increased transcript and protein levels of AHR 345 target genes (Supplemental Figure S2 
357
In the current work, we sought to identify and characterize microbial-derived metabolites that contribute 358 to colonic disease and homeostasis.
359
Immunometabolism is an area of significant interest in mucosal inflammation 33 
397
We translated these findings of shifts in indole metabolism from murine colitis to human subjects.
398
This analysis revealed, for the first time, that serum indole metabolites in human subjects with active UC 399 revealed a remarkable similarity to mice with active colitis, with the exception that human subjects were 400 selectively deficient in IPA and not indole or IAld. The reason for this selective loss of IPA in humans is 401 not known. It should be noted that indole and indole metabolites are produced by different pathways and 402 different bacteria. Since IPA is an indole derivative conjugated to propionate and propionate is among the SCFAs that become depleted in active human IBD 47 , it is possible that this selective depletion of IPA is 404 explained by an IBD-associated dysbiosis that results from the combined depletion of both SCFA-and 405 indole-producing microbiota. Further studies will be necessary to define the nature of this observation.
406
Therapeutic administration of oral IPA was protective in a murine model of colitis. Animals that 407 received IPA not only exhibited fewer physical signs of disease, but also had significantly less damage to 408 crypt structure and restricted inflammatory infiltration. Indoles and other tryptophan metabolites have been 409 demonstrated to function as AHR ligands 26, 48, 49 . It is likely that as AHR ligands, these molecules directly Tables 704 Table 1 . Primer sequences for qPCR. 
